The Influence of Medication Days’ Supply on Adherence and Cost of Hypertensive Patients at Primary Health Care Centre

Mufarrihah Mufarrihah; Catur Dian Setiawan; Nurul Wathaniah; Atikah Rahmaniah; Primanda Ayu Maharani; Azzahroh Sifa’ Lailiyah Mahmudah; Gusti Noorrizka Veronika Achmad

doi:10.14499/indonesianjpharm28iss4pp213

The Influence of Medication Days’ Supply on Adherence and Cost of Hypertensive Patients at Primary Health Care Centre

Mufarrihah Mufarrihah, Catur Dian Setiawan, Nurul Wathaniah, Atikah Rahmaniah, Primanda Ayu Maharani, Azzahroh Sifa’ Lailiyah Mahmudah, Gusti Noorrizka Veronika Achmad

Abstract

Primary Health Care Centre is known have policy discrepancy with the supply of medicines. This can influence the adherence and costs incurred by patients. The study aimed to identify the influence for hypertensive patients at Primary Health Care Centre in Surabaya. This study was designed cross sectional and data collection was done by using ARMS questionnaires for the patient's adherence and interview for the cost. Cost was calculated based on the frequency of real visits and monthly patient expenditures. Direct medical cost, direct non medical cost, and indirect cost were included based on patients’ perspective. Direct observations were done to calculate the days of drug supplies. A total of 406 patients from 50 Health Care Centre were included in the study. Days of drug supplies ranged from 3 to 30 days; total ARMS scores ranged from 12 to 33; and the total cost obtained ranged from IDR 34,965 to IDR 239,528. The Spearman’s correlation test sought to obtain the significant influence of medication days’ supply on adherence with p value 0.0001 and r = -0.347. While medication days’ supply didn't show any significant influence on the cost. It will be significant if the patient met the visit schedule, that was p value 0.0001 and r = -0.247. It is recommended to prolong antihypertensive days’ supply in order to improve patients' adherence, as well as to reduce cost expensed by patients.

Keywords

adherence, cost, hypertension, medication days’ supply, Primary Health Care Centre

Full Text:

PDF

References

Aldila, F. (2015). Kepatuhan pasien penggunaan obat antihipertensi di Puskesmas Kedurus Surabaya Selatan (skripsi). Surabaya: Fakultas Farmasi Universitas Airlangga.

Ananda, M. R. (2015). Kepatuhan penggunaan obat antihipertensi di Puskesmas Pacarkeling (skripsi). Surabaya: Fakultas Farmasi Universitas Airlangga.

BPJS Kesehatan. (2013). Seputar BPJS Kesehatan, 46.

Chobanian, A. V., Bakris, G., & Black, H. (2003). The seventh report of the joint national committee on prevention, detection, evaluation, and treatment of high blood pressure (JNC 7). Journal of Hypertension, 42(6), 1206–1252.

Depkes, R.I. (2006). Pharmaceutical care untuk pasien penyakit hipertensi. Jakarta: Departemen Kesehatan Republik Indonesia.

Dinkes Surabaya. (2015). Profil Kesehatan Tahun 2015. Surabaya: Pemerintah Kota Surabaya, Dinas Kesehatan.

Hussar, D. A. (2005). Patient Compliance. In A. R. Gennaro (Ed.), Remington: The Science and Practice of Pharmacy. (21st ed., pp. 1782–1792). Philadelphia: Lippincott Williams & Wilkins.

Kaplan, N. (2002). Kaplan’s Clinical Hypertension (8th ed.). Philadelphia: Lippincott Williams & Wilkins.

Kemenkes RI. (2013). Riset Kesehatan Dasar. Jakarta: Badan Penelitian dan Pengembangan Kesehatan Kementrian Kesehatan RI.

Kripalani, S., Risser, J., Gatti, M. E., & Jacobson, T. A. (2009). Development and evaluation of the adherence to refills and medications scale (ARMS) among low-literacy patients with chronic disease. Value in Health, 12(1), 118–123.

Osterberg, L., Blaschke, T., & Koop, — C Everett. (2005). Adherence to Medication. N Engl J Med, 353, 487–497. https://doi.org/10.1056/NEJMra050100

Riska, N. E. (2015). Kepatuhan pasien pada penggunaan obat antihipertensi dengan menggunakan metode MMAS-08 dan metode pill count di Puskesmas Tambakrejo Surabaya Pusat (skripsi). Surabaya: Fakultas Farmasi Universitas Airlangga.

Saseen, J. J., & MacLaughlin, E. J. (2008). Hypertension. In Dipiro, Pharmacotherapy: A Pathophysiologic Approach (7th ed.). New York: The Mc Graw-Hill Companies, Inc.

Sokol, M. C., McGuigan, K. a, Verbrugge, R. R., & Epstein, R. S. (2005). Impact of medication adherence on hospitalization risk and healthcare cost. Medical Care, 43(6), 521–530. https://doi.org/10.1097/01.mlr.0000163641.86870.af, accessed on October 6, 2017.

Taitel, M., Fensterheim, L., Kirkham, H., Sekula, R., & Duncan, I. (2012). Medication days’ supply, adherence, wastage, and cost among chronic patients in Medicaid. Medicare & Medicaid Research Review, 2(3), 1–13. https://doi.org/10.5600/mmrr.002.03.a04, accessed on October 6, 2017.

Voorham, J., Haaijer-Ruskamp, Flora M. Wolffenbuttel, B. H. R., Stolk, R. P., Denig, P., & Groningen Initiative Anal Type 2. (2011). Medication Adherence Affects Treatment Modifications in Patients With Type 2 Diabetes. Clinical Therapeutics, 33(1), 121–134.

WHO. (2003). Adherence to Long Term Therapies: Evidence for Action, World Health Organization. Switzerland: World Health Organization.

WHO. (2011). Hypertension Fact Sheet. Hypertension Fact Sheet. WHO Regional Office for South-East Asia. Retrieved from http://www.searo.who.int/entity/noncommunicable_disease/media/non_communicable_disease_hypertension_fs.pdf, accessed on October 6, 2017.

DOI: http://dx.doi.org/10.14499/indonesianjpharm28iss4pp213